Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST000343)

(Analysis AN000555)

Metabolite	Structure	F1	F2	F3	F4
DG (36:2) [M+Na]+	ME118487	1.16	NA	1.05	0.69
DG (36:4) [M+NH4]+	ME118489	0.91	NA	1.14	0.91
TG (58:2) [M+NH4]+_TG (58:2) [M+Na]+	ME118614	0.83	0.49	1.22	1.34
TG (60:2) [M+Na]+_TG (60:2) [M+NH4]+	ME118619	0.75	0.49	1.19	1.44
TG (56:1) [M+NH4]+_TG (56:1) [M+Na]+	ME118604	0.79	0.50	1.16	1.44
TG (58:1) [M+NH4]+_TG (58:1) [M+Na]+	ME118612	0.76	0.49	1.16	1.47
TG (53:1) [M+NH4]+	ME118593	0.86	0.72	0.97	1.29
TG (55:1) [M+NH4]+	ME118601	0.73	0.70	1.05	1.32
LPC (22:5) [M+H]+	ME118504	1.41	1.03	0.94	0.63
PC (40:5) B [M+H]+	ME118535	1.43	1.03	0.93	0.62
CE (20:3) [M+NH4]+	ME118481	0.94	0.90	1.42	0.73
LPC (22:4) [M+H]+	ME118503	1.16	1.08	0.98	0.77
PC (p-34:1) or PC (o-34:2) A [M+H]+	ME118543	1.03	0.99	1.09	0.89
PC (p-36:4) or PC (o-36:5) [M+H]+_NOID	ME118546	1.16	0.89	1.07	0.86
SM (d42:2) [M+H]+ A_NOID	ME118567	1.18	0.86	1.05	0.88
Ceramide (d40:1) [M+Na]+	ME118484	1.13	0.89	1.06	0.90
SM (d42:3) [M+H]+_NOID	ME118568	1.12	0.90	1.05	0.91
PC (38:3) [M+H]+	ME118531	1.10	0.90	1.08	0.89
SM (d40:2) [M+H]+ A	ME118563	1.11	0.87	1.10	0.90
PC (o-32:0) [M+H]+	ME118541	1.12	0.96	1.06	0.86
SM (d34:1) [M+H]+_NOID	ME118556	1.15	0.95	1.06	0.83
PC (p-40:4) or PC (o-40:5) [M+H]+	ME118549	1.11	0.93	1.03	0.92
LPC (18:0) [M+H]+_NOID	ME118496	1.09	0.92	1.06	0.91
PC (p-34:0) or PC (o-34:1) [M+H]+	ME118542	1.10	0.94	1.05	0.90
PC (p-38:3) or PC (o-38:4) [M+H]+	ME118547	1.10	0.97	1.04	0.88
SM (d33:1) [M+H]+	ME118555	1.09	0.99	1.04	0.88
SM (d34:2) [M+H]+_NOID	ME118557	1.10	0.96	1.03	0.90
PC (p-36:1) or PC (o-36:2) [M+H]+	ME118545	1.08	0.96	1.03	0.92
PC (p-42:4) or PC (o-42:5) [M+H]+	ME118550	1.08	0.96	1.03	0.91
SM (d36:1) [M+H]+_NOID	ME118558	1.17	0.93	1.02	0.87
SM (d36:2) [M+H]+	ME118559	1.15	0.96	0.98	0.90
SM (d38:1) [M+H]+	ME118560	1.13	0.96	1.01	0.90
SM (d40:1) [M+H]+	ME118562	1.12	0.97	1.01	0.88
LPC (18:2) [M+H]+_NOID	ME118498	0.99	0.84	1.14	1.00
LPC (20:1) [M+H]+	ME118500	0.98	0.83	1.15	1.00
PC (38:2) [M+H]+	ME118530	0.99	0.77	1.18	1.01
TG (58:9) [M+Na]+_TG (58:9) [M+NH4]+	ME118618	1.00	0.76	1.19	0.99
LPC (22:6) [M+H]+	ME118505	1.03	0.79	1.17	0.92
PC (34:0) [M+H]+	ME118515	1.07	0.85	1.14	0.91
PC (40:6) B [M+H]+_NOID	ME118536	1.07	0.81	1.13	0.95
PE (p-38:4) or PE (o-38:5) [M+H]+	ME118553	1.03	0.90	1.08	0.97
Ceramide (d42:1) [M+Na]+_Ceramide (d42:1) [M+H-H2O]+_Ceramide (d42:1) [M+H]+	ME118485	1.06	0.88	1.10	0.93
PC (38:6) A [M+H]+_NOID	ME118533	1.05	0.89	1.11	0.93
PC (32:0) [M+H]+	ME118510	1.06	0.92	1.08	0.92
PC (36:3) A [M+H]+	ME118525	1.07	0.90	1.09	0.92
PC (34:3) [M+H]+	ME118517	1.09	0.78	1.09	0.99
PC (32:2) [M+H]+	ME118512	1.04	0.85	1.07	1.01
PC (42:5) [M+H]+	ME118539	1.06	0.84	1.09	0.97
LPC (20:2) [M+H]+	ME118501	0.93	0.91	1.14	1.00
PC (36:2) [M+H]+_NOID	ME118524	0.95	0.92	1.09	1.02
PC (p-34:2) or PC (o-34:3) [M+H]+	ME118544	0.97	0.94	1.10	0.98
PC (35:3) [M+H]+	ME118521	0.86	0.93	1.11	1.09
PC (37:2) [M+H]+	ME118527	0.92	0.85	1.14	1.05
TG (58:10) [M+Na]+_TG (58:10) [M+NH4]+	ME118613	0.87	0.88	1.19	1.03
LPC (20:0) [M+H]+	ME118499	1.02	0.96	1.04	0.97
TG (52:3) [M+Na]+	ME118589	1.00	0.97	1.02	1.01
LPC (14:0) [M+H]+	ME118492	1.07	0.94	1.01	0.97
LPC (p-16:0) or LPC (o-16:1) [M+H]+	ME118507	1.06	0.98	0.98	0.99
PC (p-40:3) or PC (o-40:4) [M+H]+	ME118548	1.04	0.98	1.00	0.98
Acylcarnitine C18:1 [M+H]+	ME118477	1.04	1.02	1.00	0.95
LPC (16:0) [M+H]+_NOID	ME118494	1.05	1.00	1.01	0.95
LPC (p-18:0) or LPC (o-18:1) [M+H]+	ME118508	1.02	1.05	1.01	0.93
LPC (o-16:0) [M+H]+	ME118506	1.03	1.02	1.02	0.93
PC (p-42:5) or PC (o-42:6) [M+H]+	ME118551	1.03	1.03	1.02	0.93
Acylcarnitine C16:0 [M+H]+	ME118475	1.02	1.06	0.95	0.99
Acylcarnitine C18:0 [M+H]+	ME118476	0.98	1.08	0.98	0.98
SM (d42:1) [M+H]+_NOID	ME118566	0.99	1.04	1.01	0.96
SM (d44:2) [M+H]+	ME118571	0.98	1.04	1.01	0.98
PC (33:1) [M+H]+	ME118513	0.95	0.94	1.01	1.09
Ceramide (d18:1/23:0) [M+Na]+	ME118483	0.95	1.00	1.04	1.00
PC (34:2) [M+Na]+	ME118516	0.94	1.02	1.02	1.03
PC (35:4) [M+H]+	ME118522	0.91	1.03	1.00	1.07
PC (35:1) [M+H]+	ME118519	0.91	0.98	1.05	1.06
PC (37:4) [M+H]+	ME118528	0.89	1.01	1.05	1.05
PC (37:6) [M+H]+	ME118529	0.90	1.00	1.05	1.05
SM (d41:1) [M+H]+_NOID	ME118564	0.86	1.21	0.98	0.99
SM (d39:1) [M+H]+	ME118561	0.90	1.21	0.95	0.98
SM (d41:2) [M+H]+	ME118565	0.90	1.24	0.94	0.98
Acylcarnitine C18:2 [M+H]+	ME118478	0.95	1.19	0.98	0.94
CE (18:1) [M+Na]+_CE (18:1) [M+NH4]+	ME118479	0.97	1.14	0.99	0.94
CE (22:6) [M+Na]+_CE (22:6) [M+NH4]+	ME118482	0.94	1.12	1.02	0.95
SM (d43:1) [M+H]+	ME118569	1.03	1.11	0.95	0.93
SM (d43:2) [M+H]+ A	ME118570	1.01	1.18	0.90	0.95
CE (18:2) [M+Na]+_CE (18:2) [M+NH4]+	ME118480	0.73	1.30	0.95	1.08
PC (35:2) [M+H]+	ME118520	0.77	1.03	1.08	1.13
TG (49:0) [M+NH4]+	ME118575	0.82	1.03	0.92	1.27
LPC (15:0) [M+H]+	ME118493	0.86	1.11	0.94	1.11
PC (31:0) [M+H]+	ME118509	0.78	1.11	0.94	1.19
PC (33:2) [M+H]+	ME118514	0.76	1.07	1.00	1.18
TG (56:8) [M+NH4]+	ME118611	0.99	0.44	1.28	1.16
TG (51:3) [M+NH4]+_TG (51:3) [M+Na]+	ME118586	1.04	0.56	1.18	1.11
TG (55:3) [M+Na]+_TG (55:3) [M+NH4]+	ME118603	1.05	0.53	1.21	1.12
TG (53:4) [M+NH4]+	ME118595	1.03	0.57	1.26	1.05
TG (53:3) [M+NH4]+_TG (53:3) [M+Na]+	ME118594	1.10	0.57	1.21	1.03
TG (56:7) [M+Na]+_TG (56:7) [M+NH4]+	ME118610	1.07	0.60	1.24	1.00
TG (52:4) [M+Na]+_TG (52:4) [M+NH4]+	ME118590	1.04	0.70	1.16	1.03
TG (54:8) [M+NH4]+	ME118600	1.07	0.66	1.14	1.06
TG (49:2) [M+Na]+_TG (49:2) [M+NH4]+	ME118577	1.11	0.58	1.08	1.14
TG (49:1) [M+NH4]+_TG (49:1) [M+Na]+	ME118576	1.11	0.67	1.04	1.10
TG (51:1) [M+NH4]+	ME118584	1.08	0.65	1.07	1.13
TG (49:3) [M+NH4]+	ME118578	0.93	0.62	1.06	1.06
TG (55:2) [M+NH4]+_TG (55:2) [M+Na]+	ME118602	0.91	0.50	1.06	1.23
TG (51:4) [M+NH4]+_TG (51:4) [M+Na]+	ME118587	0.89	0.64	1.20	1.18
TG (58:3) [M+Na]+_TG (58:3) [M+NH4]+	ME118615	0.86	0.60	1.25	1.20
TG (54:1) [M+Na]+_TG (54:1) [M+NH4]+	ME118596	0.99	0.62	1.13	1.18
TG (56:2) [M+Na]+_TG (56:2) [M+NH4]+	ME118605	0.97	0.56	1.19	1.18
TG (46:1) [M+Na]+_TG (46:1) [M+NH4]+	ME118572	1.56	0.54	0.99	0.81
TG (48:3) [M+Na]+_TG (48:3) [M+NH4]+	ME118574	1.38	0.46	1.13	0.91
TG (50:3) [M+NH4]+	ME118582	1.37	0.42	1.20	0.88
TG (52:2) [M+NH4]+	ME118588	1.36	0.54	1.13	0.86
TG (50:1) [M+NH4]+	ME118579	1.44	0.51	1.08	0.86
TG (50:2) [M+NH4]+	ME118580	1.47	0.48	1.11	0.83
TG (46:2) [M+NH4]+_TG (46:2) [M+Na]+	ME118573	1.15	0.56	0.93	0.92
DG (36:3) [M+NH4]+_DG (36:3) [M+Na]+	ME118488	1.15	0.42	1.25	0.91
TG (56:3) [M+NH4]+_TG (56:3) [M+Na]+	ME118606	1.19	0.46	1.28	0.95
TG (50:4) [M+NH4]+_TG (50:4) [M+Na]+	ME118583	1.20	0.47	1.21	1.00
TG (51:2) [M+Na]+_TG (51:2) [M+NH4]+	ME118585	1.21	0.54	1.14	1.01
TG (52:6) [M+NH4]+_TG (52:6) [M+Na]+	ME118592	1.20	0.54	1.16	0.99
PC (32:1) [M+H]+_NOID	ME118511	1.30	0.64	1.08	0.90
TG (50:3) [M+Na]+	ME118581	1.28	0.64	1.08	0.92
TG (54:5) [M+Na]+_TG (54:5) [M+NH4]+	ME118598	1.28	0.63	1.10	0.91
PC (36:5) A [M+H]+_NOID	ME118526	1.26	0.65	1.16	0.85
DG (38:5) [M+NH4]+	ME118490	1.24	0.57	1.17	0.86
TG (56:6) [M+NH4]+	ME118609	1.23	0.61	1.18	0.90
TG (58:6) [M+Na]+	ME118616	1.24	0.59	1.20	0.88
PC (38:5) A [M+H]+_NOID	ME118532	1.12	0.68	1.17	0.95
TG (54:6) [M+Na]+_TG (54:6) [M+NH4]+	ME118599	1.15	0.65	1.15	0.97
TG (58:8) [M+NH4]+	ME118617	1.13	0.64	1.16	0.99
Ceramide (d42:2) [M+H-H2O]+_Ceramide (d42:2) [M+Na]+	ME118486	1.18	0.67	1.15	0.92
TG (52:5) [M+Na]+_TG (52:5) [M+NH4]+	ME118591	1.19	0.61	1.17	0.93
TG (54:4) [M+NH4]+	ME118597	1.17	0.54	1.24	0.95
DG (38:6) [M+NH4]+	ME118491	1.12	0.59	1.29	0.91
PC (40:7) [M+H]+_NOID	ME118537	1.11	0.60	1.26	0.94
PC (42:6) [M+H]+	ME118540	1.26	0.87	1.03	0.78
LPC (16:1) [M+H]+	ME118495	1.23	0.73	1.05	0.93
PC (34:4) [M+H]+	ME118518	1.25	0.73	1.10	0.86
SM (d32:1) [M+H]+	ME118554	1.29	0.77	1.05	0.83
TG (56:5) [M+Na]+	ME118608	1.29	0.73	1.07	0.84
PE (p-36:4) or PE (o-36:5) [M+H]+	ME118552	1.12	0.84	1.13	0.88
LPC (18:1) [M+H]+	ME118497	1.15	0.75	1.13	0.91
LPC (20:4) [M+H]+_NOID	ME118502	1.15	0.79	1.12	0.89
PC (36:1) [M+H]+	ME118523	1.17	0.78	1.10	0.91
PC (38:7) [M+H]+	ME118534	1.16	0.71	1.21	0.85
PC (40:8) [M+H]+	ME118538	1.23	0.71	1.19	0.80

Factors:

F1	Treatment:Control Diet
F2	Treatment:Resistant Starch
F3	Treatment:Whole Grain
F4	Treatment:Whole Grain + Resistant Starch

Data matrix